VEGFA and endometriosis: Angiogenesis has been suggested as a driving force behind the formation of endometriosis lesions and indeed overexpression of angiogenic growth factors such as VEGFA and increased microvessel density has been observed [194]—this has led to the idea that angiogenesis inhibitors can be used to treat endometriosis progression [195].